A Cellular Viewpoint of Anti-FVIII Immune Response in Hemophilia A
- 23 January 2009
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 37 (2) , 105-113
Abstract
A large proportion of hemophilia A patients who receive replacement therapy, develop an immune response toward the infused factor VIII (FVIII). In this review, we discuss recent progress in several aspects of the anti-FVIII immune response, focusing on the sites of FVIII endocytosis (marginal zone of the spleen and bleeding site), the type of antigen-presenting cells (dendritic cells, macrophages and B cells) and endocytic receptors, implicated in FVIII presentation to T cells during primary and secondary immune response. Although it is becoming increasingly clear that regulatory T cells are involved in FVIII tolerance in healthy subjects and potentially in patients without inhibitors, we would like to demonstrate that little is known about the different T cells subsets and the cytokines network, which are also crucial for the development of allo- and autoimmune diseases. As more information on these issues becomes available, a better understanding of the role of each immune cells compartment in promoting FVIII tolerance or inhibitors development might lead to new strategies to promote FVIII tolerance in hemophilia A patients.Keywords
This publication has 92 references indexed in Scilit:
- Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A miceBlood, 2008
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytesProceedings of the National Academy of Sciences, 2007
- Lymphoid neogenesis in chronic inflammatory diseasesNature Reviews Immunology, 2006
- T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjectsJournal of Thrombosis and Haemostasis, 2004
- Epitope repertoire of human CD4 T cells on the A3 domain of coagulation factor VIIIJournal of Thrombosis and Haemostasis, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptorsEuropean Journal of Immunology, 2002
- Regulatory Role of Cytokines in Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 2001
- Human marginal-zone B cellsImmunology Today, 1998